- Penn Medicine crisis center cuts psychiatric ED consults 80% in 6 months
- Maryland extends behavioral health provider enrollment halt
- TGH Behavioral Health launches partial hospitalization program
- NYU Langone, Mount Sinai patient records temporarily shielded from Justice Department
- UAMS to operate 53-bed Arkansas hospital, expanding clinical footprint
- New York system to close ASC, orthopedic group
- Preventing employee cynicism in a DSO
- Optum prepares to sell some New York specialties
- New York system to close orthopedic group, ASC
- CHS hospital CEO to retire after 50-year healthcare career
- Maintenance workers at 6 Prime hospitals in Illinois plan strike
- Walmart heiress’ nonprofit launches GME center to grow physician pipeline
- Optum prepares to sell some New York specialties
- Senate bill aims to expand rural surgery care
- Memorial Sloan Kettering breaks ground on $2.3B cancer center
- Ohio dentist to pay $500,000 to resolve False Claim Act allegations
- Lawmakers aim to fight ‘surgical deserts’ with new bill
- 9 schools training the next wave of ASC anesthesiologists
- 3 Washington dental offices pay $1M to settle Medicaid fraud allegations
- Why Ascension believes ASCs need a rebrand
- How long can health systems afford rising provider pay?
- Illinois behavioral health CEO charged in $75M Medicaid fraud case
- The anesthesia desert: 8 states, no residency programs, no pipeline
- The CRNA cost cliff
- Is private equity’s healthcare bubble about to burst?
- States ranked by anesthesiologists per capita
- ASCs’ lease liability
- Arizona behavioral health provider email breach affects 2,316
- Akron Children’s adds 24/7 text-based mental health support
- Kaiser Health Plan ordered to pay hospital $82M over insufficient reimbursement
- Dentistry’s highest-paid CEO
- US health spending set to reach $9T by 2034: CMS report
- What behavioral health leaders need to know about Medicaid work requirements
- Trial set for man accused of dental office shooting
- Utah halts new behavioral health Medicaid enrollments
- BCBS Michigan to supervised BH clinicians: Bill directly or face payment cuts
- Vitana Pediatric & Orthodontic Partners expands capital structure with new financing partner
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
- Senators call for $50B rural health fund to better target small providers, relax spending restrictions
- Florida AG to probe CVS for anticompetitive pharmacy practices
- Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
- UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates
- Even 5-Minute Movement Breaks Can Boost Your Mood And Fight Fatigue
- Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report
- Stada, under new CapVest ownership, picks up horde of European consumer brands
- Belly Laughs Spring From The Primitive Brain, Researchers Say
- Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
- Accelerated Aging May Explain Rising Cancer Risk In Young Adults
- Coval raises $28M series A to address AI voice agent reliability, compliance
- Amid safety concerns, ADC Therapeutics plots 17% staff cuts to push resources behind Zynlonta
- Racial Gaps Narrow For U.S. Cancer Deaths, Report Finds
- Medicare's AI Push Snarls Patients And Doctors In Errors And Delays
- Even in Blue States, Hospitals Have Continued To Drop Gender-Affirming Care for Youths
- Patients prefer healthcare providers' AI agents to public chatbots, with human oversight non‑negotiable, survey finds
- Revance taps dancer Julianne Hough to choreograph social media push for Botox rival
- Western University opens multidisciplinary dental clinic
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
- Oral Surgery Partners adds Pennsylvania practice
- Rock Dental Brands marks record growth during first half of 2026: 4 notes
- Connecticut woman accused of stealing $78K from dental office
- Some life insurers compete with health insurers on benefits. Here's why
- DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
- Psychologists sound alarm on patients using AI for mental health: 5 notes
- Locum tenens coverage becoming ‘more purposeful’ staffing strategy: Definitive Healthcare
- Testosterone Therapy Labels And Limits May Change Under FDA Proposal
- Unpacking CMS' decision to recalculate 2026 MA star ratings after Clover Health ruling
- Michigan hospitals denounce legislation to cap prices, limit mergers
- Incyte drops lawsuit as CMS relents on classification of Opzelura
- Medicare’s AI push snarls patients and doctors in errors and delays
- Midlife Strength Training Linked to Lower Diabetes Risk
- Badges, bots and blind spots
- Cadence secures $100M series C to advance AI-powered care for chronic disease
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- Hallmark Health Care Solutions launches AI solution to tackle workforce ‘black box’
- AdvanCell locks in lease for US headquarters, radiopharmaceutical production near Boston
- Novartis’ ‘Relax Your Tight End’ prostate cancer campaign wins Cannes Lions Pharma Grand Prix
- These 'socially responsible' hospitals deliver on quality, value and equity
- A look at Elevance Health's push to streamline clinical reviews
- Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair
- Big obesity bets and China's rise fuel potential $2T in 2032 drug sales: Evaluate
- Patient portal messages doubled since 2020, study finds, underscoring challenges to physician workloads
- HCSC unveils Easify Edge plans as alternative employer option
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Half of U.S. adults can't afford healthcare, Gallup poll finds
- Ensemble Health Partners secures strategic growth investment from Thoreau
- Hospital margins inched higher in April, but still remain below 2025
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CARsgen makes history as China approves world's first CAR-T therapy for solid tumors
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- US to investigate Germany's proposed drug spending reforms
- Alnylam scolded over promotional activity after Pfizer complaint
- Real-world data powers next-gen biopharma
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Why a deviation investigation still takes two weeks in the age of AI
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
- They’re Uninsured After Obamacare Became Too Costly. And They’re Far From Alone.
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
Michigan healthcare freedom community forum
The Food and Drug Administration wants to regulate all Laboratory Developed [Medical] Tests (LDTs), also known as In Vitro Diagnostic (IVD) products. Their rule, Docket No. FDA-2023-N-2177, was published in the Federal Register on October 3, 2023. Comment period has since closed, but the rule's future is in doubt:
https://www.fda.gov/media/172557/download?attachment
https://reason.com/2024/03/28/fda-to-test-more-tests/
FDA Aims To Stifle Medical Innovation Again
After botching COVID test approvals, the Food and Drug Administration wants power over thousands of other tests.
By Ronald Bailey | April 2024The Food and Drug Administration (FDA) that massively screwed up COVID-19 testing now wants to apply its vast bureaucratic acumen to all other laboratory developed tests (LDTs). By insisting on its recondite approval procedures, the FDA at the beginning of the pandemic stymied the rollout of COVID-19 tests developed by numerous academic and private laboratories. In contrast, public health authorities in South Korea greenlighted an effective COVID-19 test just one week (and many more in the weeks following) after asking representatives from 20 private medical companies to produce such tests.
LDTs are diagnostic in vitro tests for clinical use that are designed, manufactured, and performed by individual laboratories. They can diagnose illnesses and guide treatments by detecting relevant biomarkers in saliva, blood, or tissues; the tests can identify small molecules, proteins, RNA, DNA, cells, and pathogens. For example, some assess the risks of developing Alzheimer's disease or guide the treatment of breast cancer.
The FDA now wants to regulate these tests as medical devices that must undergo premarket agency vetting before clinicians and patients are allowed to use them. The FDA estimates that between 600 and 2,400 laboratories currently offer as many as 40,000 to 160,000 tests. Overall, some 3.3 billion in vitro tests are administered to patients annually.
Out of billions of tests given, how often do laboratory developed tests appear to cause harm? In its submissions, the FDA justifies this burdensome oversight by citing problematic medical device reports and unconfirmed "allegations" for a grand total of nine and four different tests respectively between 2009 and 2023. The remaining examples cited by the FDA are tests that had actually been submitted to the agency for analysis and were subsequently rejected or revised as recommended.
A 2023 study in the American Journal of Clinical Pathology analyzed how frequently these tests were deployed in the University of Utah health system. The researchers reported that out of the more than 3 million lab tests ordered in 2021, 94 percent of them had already been approved by the FDA. Only 4 percent of the lab tests were LDTs. They believe their figures are similar across the U.S. health care landscape.
The FDA has received strong and widespread pushback from laboratories and clinicians. In a letter to the agency, American Hospital Association Executive Vice President Stacey Hughes wrote of the proposed regulations that "the unfortunate outcome likely would be the decline in the rate of clinical innovation, which would negatively impact the U.S.' ability to keep our health care system at the forefront of discovery, provide quality care to patients, and respond quickly to emerging public health risks."
The Biden administration is aiming to have the regulations finalized in April. However, MedTech Dive reports, analysts at the investment bank TD Cowen suggested that it remains "unclear if and when FDA will finalize the rule as it has faced considerable opposition and would likely be challenged in court."
Nothing succeeds in the Federal Government like repeated failure. 😡
Seriously, this is a terrible idea!
Creeping regulation limits our access to care. What's difficult about this??
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The agency cannot stand by while Americans continue to rely on results from these tests without assurance that they work,” FDA Commissioner Robert Califf told reporters on a conference call.
Califf said inaccurate tests can lead to unnecessary treatment or delays in getting proper care.
But in a significant move, the FDA decided that the tens of thousands of tests currently on the market will not have to undergo federal review. The agency said it will essentially grandfather those tests into approval to address concerns that the new rule “could lead to the widespread loss of access to beneficial” tests.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
J & DE Family Charitable Fund
Friends
of MHF
Kelly Grotendiek
Philip Harbach
Dale Johnson
Drs. Jeffrey and Joni Jones
Vickie Kahle
Tammy Kipen
Marlin & Kathy Klumpp
Melanie Kurdys
Ruth Nobel
Patrick Peterson
Stephanie Poortenga
Jeanne Smit
Ben and Hope Staal
John Tuinstra
Jacki VanHuis
Sandy Walker
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
